MOODY LYNN & LIEBERSON, LLC Relmada Therapeutics, Inc. Transaction History

MOODY LYNN & LIEBERSON, LLC portfolio value:

$2.40M
portfolio value

Relmada Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 65.05K shares 2.40M $37.02 65.05K